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Peptide mass mapping plays a central role in the structural characterization of protein variants
with single amino acid substitutions. Among the 20 standard amino acids found in living
organisms, 18, all but Leu and Ile, differ from each other in molecular mass. The mass
differences between amino acids range from 0.0364 to 129.0578 Da. The mass of the mutated
peptide or the difference between normal and mutated peptides uniquely determines the type
of substitution in some cases, and even pinpoints the position of the mutation when the
involved residue is found only once in the peptide. Among 75 pairs of amino acid residues that
are exchangeable via a single nucleotide replacement, 53 show specific change in exact mass,
while only 25 in nominal mass. On the other hand, precise measurement, at least to the third
decimal place, greatly enhances the capacity of the peptide mass mapping strategy for
structural characterization. This notion was verified by an analysis of three Hb variants using
MALDI-FTICR MS. In addition, the baseline resolution of two 1 kDa peptides with a single
amino acid difference, Lys or Gln, which have the smallest (0.0364 Da) difference among
residues, was achieved by measurement at a mass resolving power of 342,000. The results
indicated that the smallest difference, 0.0040 Da between [29.9742 for Glu-Val] and [29.9782
for Trp-Arg], among all types of amino acid substitutions derived from a single nucleotide
replacement can be discriminated at the present performance level. Therefore, FTICR MS is
capable of identifying all 53 types of substitutions, each of which is associated with a unique
mass difference, except for the Leu and Ile isomers. (J Am Soc Mass Spectrom 2006, 17,
508–513) © 2006 American Society for Mass SpectrometryMany diseases are caused by a single nucleotidesubstitution in the coding region of the respon-sible gene. This type of mutation produces mu-
tated proteins with single amino acid substitutions, unless
the resulting codon terminates translation or the mutated
mRNA or proteins are quite unstable. The mass spectro-
metric strategy of characterizing themutated proteins was
established a decade ago, mostly utilizing hemoglobin
(Hb) variants as a model protein [1– 6]. The approach
involves two steps: molecular mass measurements of
intact proteins [7], and peptide mass mapping of enzy-
matic digests [8, 9]. Detection of the molecular mass
change caused by an amino acid substitution is an essen-
tial part of either analysis.
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doi:10.1016/j.jasms.2005.12.006Among the 190 pairs formed by the 20 standard
amino acids, only an exchange of Leu and Ile results in
the same elemental composition, and therefore cannot
be characterized on the basis of molecular mass. Other
types of exchange accompanying a mass shift from
0.0364 Da for Glu-Lys to 129.04578 Da for Trp-Gly are
theoretically amenable to the mass-based strategy.
More importantly, according to the point mutation rule,
the size of a mass shift uniquely defines the type and
position of the substitution in many cases, as discussed
in earlier studies [1, 10]. In addition, another rule of
genetics in nature, where the vast majority of amino
acid substitutions are caused by single nucleotide sub-
stitutions, facilitates the mass-based elucidation, be-
cause only 40% of the 190 different types of amino acid
substitutions are derived from a single nucleotide sub-
stitution. Although some types of amino acid mutations
are indistinguishable from each other because they
involve the exact same change in elemental composi-
tion, the capability of this strategy depends on the
resolution of the measurement. For example, two amino
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509J Am Soc Mass Spectrom 2006, 17, 508–513 PEPTIDE MASS MAPPING WITH FT-ICR MSacid substitution types, Phe-Asp and Tyr-Asp, give the
same nominal mass shift of 48 Da, but differ from each
other by 0.03639 Da being 48.00000 Da versus
48.03639 Da, respectively.
Human Hb is a tetrameric protein in erythrocytes
and is comprised of two globin molecules,  and 
subunits, each of which bears a prosthetic heme. The
subunits of adult Hb (Hb A) are composed of 141 amino
acid residues (Mr  15,126.4) for  and 146 amino acid
residues (Mr  15,867.2) for , respectively. Most of the
Hb variants are caused by an amino acid substitution in
one of these subunits and are derived from a single
nucleotide change in the gene. In most cases, the
exception being highly prevalent mutations such as that
causing sickle cell disease, Hb mutations are heterozy-
gotic and thus both the normal peptide and its mutated
counterpart are present in the patient.
Herein, precise measurement of the difference in the
masses of normal and mutated peptides was carried out
by Fourier transform ion cyclotron resonance (FTICR)
MS [11]. The results demonstrate precise measurements
to greatly enhance the capability of peptide mass map-
ping for structural characterization of amino acid sub-
stitutions in protein variants.
Materials and Methods
Materials
Three hemoglobin variants, HbMoriguchi (97His¡Tyr),
Hb G Coushatta (22Glu¡Ala), and Hb J Cape Town
(92Arg¡Gln), with known structures [2, 4, 5] were
employed in this study. An enzymatic digest of globins
was prepared according to methods described previously
[2, 10]. The mutated peptide of Hb G Coushatta was
purified by reversed-phase chromatography for MS/MS.
Synthetic peptides, LQQCPFEDH (1115.4706 Da)
and LKQCPFEDH (1115.5070 Da), were purchased
from Sigma (St. Louis, MO).
MALDI-FTICR MS
MS was performed in positive ion mode using a
Table 1. Mass differences between peptides of wild-type and m
Amino acid O
Wild 97His 1
Moriguchi 97Tyr 1
Mass-shift His-Tyr 
Wild 92Arg 1
J Capetown 92Gln 1
Mass-shift Arg-Gln
Wild 22Glu 1
G Coushatta 22Ala 1
Mass-shift Glu-AlaMALDI-FTICR mass spectrometer (IonSpec, Lake For-est, CA) equipped with an actively shielded 7-tesla
superconducting magnet (Cryomagnetics, Oak Ridge,
TN). An air-cooled Nd:YAG laser system (New Wave,
Fremont, CA) was used for ionization and desorption.
The sample was mixed with 50 mg/mL recrystallized
2,5-dihydroxybenzoic acid on a stainless steel target. All
mass spectra were acquired in single non-repetitive
shot mode followed by a single scan, because multiple
shot mode and accumulation of scans impair mass
accuracy. Each measurement was repeated 20 times.
The protonated molecules for the peptides, except those
involved in the mutation, were used for the internal
mass calibration.
Fragmentation of the peptides was accomplished by
sustained off resonance irradiation and collision-in-
duced dissociation (SORI-CID).
Statistical Analysis
Confidence intervals (CI) were calculated with Stu-
dent’s t-distribution.
Results
In the peptide mass mapping for detection of mutations,
tryptic digestion is most often used and the resulting
peptides have a mass of 1000 Da on average. The mutated
peptides are T11 (peptide no.11 of tryptic digest of
-globin chain) for Hb Moriguchi and T3 for Hb G
Coushatta, and the molecular masses for the correspond-
ing wild peptides are 1125.5567 and 1313.6575, respec-
tively. For Hb J Cape Town, digestion with lysylendopep-
tidasewas applied, as the substitution of Gln for Arg turns
off the tryptic cleavage at themutated site, and the peptide
L9 (peptide no. 9 of lysylendopeptidase digest of -glo-
bin chain) with an exact molecular mass of 1086.6186 for
the wild type is the target in this case. All these mutations
are heterozygotic and the variants are present at50%, as
are their normal counterparts. The FTICR MS of these
peptides represented the mass accuracy within a few ppm
t globins
m/z
ved Theoretical Error ppm
659 1126.5645 1.25
703 1152.5689 1.21
044 26.0044 0.38
270 1087.6264 0.64
846 1059.5839 0.51
424 28.0425 4.28
670 1314.6654 1.19
616 1256.6599 1.36
054 58.0055 2.14utan
bser
126.5
152.5
26.0
087.6
059.5
28.0
314.6
256.6(Table 1).
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The normal sequence of T11 is LHVDPENFR. The
MALDI-FTICR mass spectrum of a tryptic digest is
presented in Figure 1, and the signals at m/z 1126.5638
Figure 1. MALDI-FT-ICR mass spectra of tryptic digest of carb-
amidomethylated  and  globins of Hb Moriguchi. (a) Full
spectrum. (b) Depicted spectrum for protonated T11 region. The
ions for normal and mutated (T11=) peptides are observed at m/z
1126.5638 and 1152.5689, respectively, since the mutation was
heterozygotic. Normal T11 sequence is LHVDPENFR.
Table 2. The 99% Confidence Intervals (CI) for each measured m
CI
Hb Moriguchi [26.004094,26.004686]
Hb J Cape Town [28.041776,28.042984]
Hb G Coushatta [58.004628,58.006082]and 1152.5689 are the ions for wild and mutated T11
peptides, respectively. The difference in nominal mass
is 26 Da, suggesting five different types of mutations:
His¡Tyr (26.0044), Ala¡Pro (26.0157), cmCys
(carbamidomethylcysteine)¡Trp (26.0487), Ser¡Ile
(26.0520), and Ser¡Leu (26.0520) (exact mass in paren-
theses and unmodified cysteine excluded). In light of
the point mutation rule, only His¡Tyr is ascribed to the
molecular mass shift of this peptide, because none of
the other residues, Ala, Cys, or Ser, are present in the
wild T11 peptide. This assumption can be confirmed
statistically by precise measurement of the mass shift as
follows.
The mean of 20 mass difference measurements was
26.00439, and the standard deviation was 0.00046.
Therefore, the 99% confidence interval (CI) is
[26.004094, 26.004686], and only Tyr¡His among the
five types of substitutions described above lies within
the 99% CI (Table 2). The position of the mutation was
unequivocally demonstrated to be at the single Tyr, the
second residue of T11.
Hb J Cape Town (92Arg¡Gln)
The normal sequence of L9 peptide is LRVDPVNFK.
In the MALDI-FTICR mass spectrum, the ions at m/z
1087.6267 and 1059.5841 are derived from wild and
mutated peptides, respectively (Figure 2). The mean of
20 mass difference measurements was 28.04238 Da, and
the 99% CI was [28.041950, 28.042803]. Only the
Arg¡Gln mutation giving the calculated shift of
28.0425 Da lies within the 99% CI (Table 2), while the
nominal mass difference of 28 Da suggested five differ-
ent types of mutations: Asp¡Ser (27.9949), Glu¡Thr
(27.9949), Arg¡Lys (28.0061), Val¡Ala (28.0313), and
Arg¡Gln. Since one Arg residue is present in the
sequence, the substitution is uniquely located at that
position.
Hb G Coushatta (22Glu¡Ala)
The normal sequence of T3 peptide is VNVDEVG-
GEALGR. The signals at m/z 1256.6614 and 1314.6670
are protonated T3 from mutated and wild globins,
respectively (Figure 3a and b). The difference in nomi-
nal mass suggests four different types of mutations:
Trp¡Lys (57.9844), Asp¡Gly (58.0055), Glu¡Ala
shift and the nearest () and the second nearest mass-shifts
Theoretical mass shift Mutation
26.0044 (Tyr-His)
26.0157 (Pro-Ala)
28.0313 (Val-Ala)
28.0422 (Arg-Gln)
58.0053 (Glu-Ala)ass-58.0207 (Trp-Gln)
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ence was 58.0054  0.0014 Da, and the 99% CI was
[58.004628, 58.006082]. These results ruled out two
types of substitutions, Trp¡Lys and Trp¡Gln, leaving
two possible mutations, Asp¡Gly and Glu¡Ala. Since
in total three Asp or Glu candidate residues are present
in the sequence of T3, the type and position of the
mutation cannot be uniquely determined solely by the
mass shift. SORI-CID was thus used to determine the
structure of the mutated peptide in this case. In the
MS/MS spectrum shown in Figure 3c, the y9 ion at m/z
812.4564 contained the Glu¡Ala mutation at either the
fifth or the ninth residue from the N-terminal. Finally,
the mutated site was determined to be the former by the
MS/MS/MS spectrum, in which the normal mass for
the y7 ion was generated from the y9 ion observed in the
Figure 2. MALDI-FT-ICR mass spectra of the Lys-C digest of
carbamidomethylated  and  globins of Hb J Cape Town. (a) Full
spectrum. (b) Depicted spectrum for protonated L9 region. The
ions for normal and mutated (L9=) peptides are observed at m/z
1087.6267 and 1059.5841, respectively. Normal L9 sequence is
LRVDPVNFK.MS/MS spectrum (Figure 3d).Minimal Mass Shift of Gln-Lys in a 1 kDa Peptide
The smallest mass shift produced by an amino acid
substitution is 0.0364 Da. This shift is derived from an
exchange of Gln for Lys or vice versa. Theoretically,
separation of two 1 kDa peptides bearing a mass
difference of this size requires a resolution of 30,000,
which is readily achievable with a broadband scan. To
demonstrate the separation capacity of FTICR MS, two
homologous peptides, LQQCPFEDH (1115.4706 Da)
and LKQCPFEDH (1115.5070 Da), were synthesized
and the mixture was analyzed. The baseline resolution
of these peptides was achieved by the MALDI-FTICR
mass spectrum at a mass resolving power of 342,000
(Figure 4).
Discussion
Although structural characterization of protein variants
is currently performed by DNA sequence analysis in
most cases, MS still plays a central role in characterizing
some systemically abundant proteins that can be easily
obtained [12, 13]. A typical example is Hb, a number of
mutations of which have been characterized by MS [2,
8, 14, 15]. Analysis of the mass of intact proteins is
useful for detecting mutations in small proteins such as
globins, but the determination of the type and position
of such a mutation awaits peptide mass mapping of an
enzymatic digest. In analysis of either proteins or pep-
tides, precise measurement of a mass shift derived from
the point mutation is essential [16, 17], while the Leu
and Ile isomers, which can be exchanged with a single
nucleotide replacement, are not amenable to this strat-
egy. In the present study, the amino acids with the next
smallest difference, Lys and Gln, could be discrimi-
nated in a 1 kDa peptide, the average size of tryptic
peptides (Figure 4).
In some cases, the type of mutation is uniquely
determined by the size of the molecular mass change in
peptides, and the site may also be identified when the
residue appears only once in the sequence [2]. In this
respect, the present study has demonstrated that the
precise measurement greatly enhances the capability of
peptide mass mapping compared with conventional
analysis on a nominal-mass basis. This notion is sup-
ported by the following theoretical considerations.
Among 190 different pairs of standard amino acids,
23 have unique differences in nominal mass. For exam-
ple, His and Glu are the only pair that differs from each
other by 8 Da, but this type of amino acid substitution
requires a double nucleotide replacement in the codon.
On the other hand, there are 75 pairs of residues that
can be exchanged with single nucleotide substitutions,
and only six pairs among them, His-Asp (22 Da),
Arg-Cys (53 Da), Arg-Pro (59 Da), Arg-Ser (69 Da),
Trp-Cys (83 Da), and Trp-Gly (129 Da), have unique
mass differences even on a nominal-mass basis. These
six can be readily characterized by straightforward
conventional measurements. However, this highlights
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type of mutation in many cases. For example, there are
ten different pairs, Asp-Val, Glu-Leu, Glu-Ile, Cys-Ser,
Ser-Ala, Tyr-Phe, Met-Asp, Phe-Met, Leu-Pro, and Ile-
Pro, having a difference of 16 Da, of which five (Asp-
Val, Cys-Ser, Ser-Ala, Tyr-Phe, and Leu-Pro) can be
derived from a single nucleotide substitution. On the
other hand, in terms of exact mass, only two, Ser-Ala
and Tyr-Phe, in the latter subgroup have the same
15.9949 Da difference. In this way, among a total of 190
pairs, 121 have unique changes in terms of exact mass
and, therefore, can be discriminated from each other by
precise measurement. When limited to single nucleo-
tide substitutions, 54 (72%) of 75 types of exchange have
Figure 3. MALDI-FT-ICR mass spectra of the t
(a) Full spectrum. (b) Depicted spectrum for pro
(T3=) peptides are observed at m/z 1314.6670
spectrum of the purified T3=. The mutated pe
tography and subjected to SORI-CID. Three y-ser
ion spectrum of the y9 observed in the MS
2 s
GEALGR.specific differences in size (including 0 for Leu-Ile), i.e.,in exact mass, while only 25 types (33%) differ in
nominal mass (Figure 5). Among the remaining 21 pairs
that cannot be specified on the basis of exact mass, those
with a difference of 14.0157 Da for CH2 (Ala-Gly,
Thr-Ser, Leu-Val, Ile-Val, and Glu-Asp) constitute the
largest group.
Obviously, 54 different sizes of mass shift associated
with amino acid substitutions represent the difference
in elemental composition of residues. For example, the
shift of 26.0044 by the mutation His¡Tyr of Hb
Moriguchi is calculated from the difference in the
compositions of His and Tyr, [C6H7N3O] versus
[C9H9NO2], namely [C3H2O-N2]. The smallest differ-
ence between amino acids is 0.0364 Da, resulting from
c digest of  and  globins of Hb G Coushatta.
ed T3 region. The ions for normal and mutated
1256.6614, respectively. (c) MS2 product ion
T3= was purified by reversed-phase chroma-
ns, y4, y9, and y11 are observed. (d) MS
3 product
um. The normal T3 sequence is VNVDEVG-rypti
tonat
and
ptide
ies io
pectran exchange of Lys and Gln, and the difference in the
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the smallest difference between substitutions (from a
single nucleotide replacement) is 0.0040 Da, the differ-
ence between [29.9742 for Glu-Val] and [29.9782 for
Trp-Arg], and the method described herein can discrim-
inate this small difference as suggested by the accuracy
Figure 4. MALDI-FT-ICR mass spectra of a mixture of synthetic
peptides with a mass difference of 0.0364 Da. The protonated
peptides with sequences of LQQCPFEDH and LKQCPFEDH are
observed at m/z 1116.4784 and 1116.5148, respectively, displaying
baseline separation.
Figure 5. Amino acid replacement pairs with respect to the
causative nucleotide substitution and resulting mass shift. There
are 190 pairs (Groups A  B) of standard amino acids, and 75
(Group B) can be derived from single nucleotide replacements in
the genetic code. Exchange in the Group A pair is extremely rare.
In Group B, 54 pairs (Groups C  G) have a specific difference in
exact mass between the amino acids involved, and can thus be
discriminated from each other, while the others (F) do not. Among
the 54 pairs (Groups C  G), 25 pairs (Group D) are unique in
nominal mass. Therefore, 53 pairs (Group G), the exception being
the isomer pair (Group C) of Leu and Ile, are determined by
precise measurements. The number of pairs is indicated in paren-
theses.shown in Table 1. In conclusion, peptide mass mapping
by FTICR MS is capable of identifying all 53 types (106
types when A¡B and B¡A are counted separately) of
substitutions which are caused by single nucleotide
substitutions and have unique mass shifts.
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